Navigation Links
New STELARA data show inhibition of joint destruction in active psoriatic arthritis
Date:10/28/2013

San Diego, October 28, 2013 -- New findings from two integrated Phase 3 Janssen Research & Development, LLC (Janssen)-sponsored studies showed treatment with STELARA (ustekinumab) resulted in significantly greater inhibition of structural damage in patients with active psoriatic arthritis compared with placebo. Pre-specified integrated analyses from the PSUMMIT I and II trials showed treatment with either STELARA 45 mg or 90 mg resulted in significantly less change from baseline at week 24 in total psoriatic arthritis modified van der Heijde-Sharp (vdH-S) scores compared with placebo. STELARA-treated patients from the combined data analysis of both trials demonstrated continued inhibition through one year and through two years according to findings from the PSUMMIT I trial. These results are being presented during the 2013 Annual Meeting of the American College of Rheumatology (ACR). STELARA recently received approval from the U.S. Food and Drug Administration (FDA) and approval from the European Commission for the treatment of signs and symptoms in adult patients with active psoriatic arthritis.

"Data from the integrated analysis of the Phase 3 clinical program show the efficacy of the interleukin-12/23 antibody STELARA in inhibiting the progression of structural damage in patients with active psoriatic arthritis," said Iain B. McInnes, PhD, FRCP, Professor of Medicine, and Director of the Institute of Infection, Immunity, and Inflammation, University of Glasgow, Scotland, lead study investigator. "These new findings are significant since impeding further joint damage is an important part of the long-term management of this chronic inflammatory disease."

According to a pre-specified integrated analysis of the two Phase 3 Multicenter, Randomised, Double-blind, Placebo-controlled trials of Ustekinumab, a Fully Human anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Active Psoriatic Arthritis (PSUMMIT I
'/>"/>

Contact: Brian Kenney
BKenney1@its.jnj.com
215-628-7010
Tonic Life Communications USA
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Alzheimer's Pilot Study Proposed for Ustekinumab (Stelara)
2. Specific inhibition of autophagy may represent a new concept for treatment of kidney cancer
3. Treating drug resistant cancer through targeted inhibition of sphingosine kinase
4. Novel test identifies patients most likely to benefit from ALK inhibition therapy
5. Neurological Wellness Center's Novel Neuro-Inflammation Inhibition Procedure that Induces Rapid Recovery from Alzheimer's, Stroke and Brain Injury is Now Being Taught in a Newly Released Video
6. Epoxide hydrolase inhibition and Thiazolidinediones: A therapy for cardiometabolic syndrome
7. Joint-Replacement Failure Rate Higher for Smokers: Studies
8. Soy-based S-equol supplement reduces hot flash frequency, muscle & joint pain in US women
9. Obesity, Diabetes May Raise Complications After Joint Replacement
10. Oxford University Press acquires joint ownership of Journal of Surgical Case Reports
11. Joint Replacement Boosts Heart Attack Risk Right After Surgery: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... developing, bringing with its advances promises of individualized ... treatment interventions. Genetic tests are already guiding ... hepatitis c virus (HPC), and emerging research is ... for an individual,s susceptibility to addiction to a ... While there appear to be many benefits inherent ...
(Date:9/23/2014)... 2014 Grinnell Mutual seeks submissions ... in the Midwest. Working Together Making It Better ... organizations with projects positively impacting their communities. , ... make their communities a better places,” said ... Relations Barb Baker. “Their leadership—as coaches, as volunteers, ...
(Date:9/23/2014)... News) -- The number of ,rogue, wholesale distributors ... so doctors need to be vigilant when purchasing ... Tuesday. In a statement, the agency said ... launched a program to educate doctors and other ... purchasing procedures. The program aims to protect patients ...
(Date:9/23/2014)... showing the benefits of preventing a reduction in ... was released today by the American College of ... Save the Medicaid Primary Care Pay Parity Program: ... Life-Saving Primary Care Will Expire," explains why it ... internists and pediatricians (and their related subspecialists), family ...
(Date:9/23/2014)... Viejo, California (PRWEB) September 23, 2014 ... the Oracle services market. Included are Oracle ... Resource Augmentation. Trevera supports all versions of Oracle ... associated point releases. , Trevera has announced ... for organizations that need help with their software ...
Breaking Medicine News(10 mins):Health News:NYU-Mount Sinai Beth Israel study explores drug users' opinions on genetic testing 2Health News:Grinnell Mutual Invites Submissions for Innovative, Collaborative Local Projects in Its Second Annual Working Together Making It Better Promotion 2Health News:Unless Congress acts, patients may soon lose access to primary care 2Health News:Unless Congress acts, patients may soon lose access to primary care 3Health News:Trevera, Inc adds Management Support to Services 2Health News:Trevera, Inc adds Management Support to Services 3
... RIDGE, N.J., Feb. 20 When Avaya ... exhibition show floor of HIMSS08,next week, onboard ... Communications,solutions that are helping healthcare organizations address ... Avaya Inc.,is a leading global provider of ...
... HATBORO, Pa., Feb. 20 InfoLogix, Inc.,(Nasdaq: ... mobility,solutions for the healthcare and commercial industries, announced ... at the Growth & Value,Investor Conference to be ... on,February 27-28, 2008., (Logo: http://www.newscom.com/cgi-bin/prnh/20071101/NETH165LOGO ...
... Existing ... Vendor ... of,point-of-care charge capture technologies, today announced that Kentucky,Medical Services Foundation ... clinician base of more than 600 providers., MedAptus, Professional ...
... Cyberonics, Inc. (Nasdaq:,CYBX) today announced results for the ... Financial highlights, Net sales, Net sales ... million,compared to $28.9 million in the second quarter of ... fiscal 2007. Net sales for the nine months,ended January ...
... Evidence Base for MEDIHONEY(TM) Dressings Growing, PRINCETON, ... Board: DSCI), a provider of advanced wound care ... usage of its,newly released MEDIHONEY(TM) Wound & Burn ... at the upcoming annual,American Professional Wound Care Association ...
... Las Vegas Training Facility, FREMONT, Calif., Feb. ... and aesthetic lasers, today announced an agreement with,The ... an,internationally recognized leader in post-graduate dental education, in,which ... utilized at,LVI,s state-of-the-art teaching facility through 2009. The ...
Cached Medicine News:Health News:Avaya Unified Communications Solutions Help Healthcare Organizations Address Multi-Site, Mobile Workforce Challenges 2Health News:Avaya Unified Communications Solutions Help Healthcare Organizations Address Multi-Site, Mobile Workforce Challenges 3Health News:Avaya Unified Communications Solutions Help Healthcare Organizations Address Multi-Site, Mobile Workforce Challenges 4Health News:InfoLogix, Inc. to Present at the Growth & Investor Conference in Fort Lauderdale, FL 2Health News:InfoLogix, Inc. to Present at the Growth & Investor Conference in Fort Lauderdale, FL 3Health News:MedAptus Selected by Kentucky Medical Services Foundation for Professional Charge Capture Technology 2Health News:MedAptus Selected by Kentucky Medical Services Foundation for Professional Charge Capture Technology 3Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 2Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 3Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 4Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 5Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 6Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 7Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 8Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 9Health News:Derma Sciences Announces Several Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming APWCA Conference 2Health News:Derma Sciences Announces Several Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming APWCA Conference 3Health News:Derma Sciences Announces Several Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming APWCA Conference 4Health News:HOYA ConBio Announces Educational Agreement With LVI Global 2
(Date:9/23/2014)... and DUBLIN , ... TNIB) ("we" or the "Company"), a biotechnology company ... for autoimmune diseases in emerging nations, today announced ... our common stock for DTC,s Deposit and Withdrawal ... Securities Transfer Service ("FAST") transfer agent as the ...
(Date:9/23/2014)... 23, 2014 Research and Markets  has announced ... report to their offering. Diabetes is ... globe. Over 382 million people are estimated to be currently ... to 592 million by 2035. With a very high ... and India , an increasing ...
(Date:9/23/2014)... -- The Pennsylvania State Police will accept unwanted, expired and ... National Prescription Drug Take-Back Day. The service is free ... is a national initiative, conducted in partnership with the ... public to dispose of expired, unused or unwanted prescription ... From 10 a.m. to 2 p.m., unwanted prescription ...
Breaking Medicine Technology:TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 3TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 4Glycated Haemoglobin (HbA1c) Testing Market 2Glycated Haemoglobin (HbA1c) Testing Market 3
... Techne Corporation,s (NASDAQ: TECH ) financial results for ... First quarter earnings were $27.5 million or $.74 ... to $30.0 million or $.81 per diluted share after adjustment ... of inventory that was written-up to fair value as part ...
... PAREXEL International Corporation (NASDAQ: PRXL ... today announced that the Company has expanded ... dedicated support for their commercialization goals ... services to help clients maximize regional and global ...
Cached Medicine Technology:Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 2Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 3Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 4Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 5Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 6Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 7Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 8PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value 2PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value 3PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value 4PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value 5
... The HDR disposable template is ... contamination and eliminate the need ... made with premium silicone molded ... ensures accurate needle placement while ...
A sterile, cost-effective solution to eliminating the risk of cross-contamination....
... Reusable Template is designed for use ... system for prostate brachytherapy. Please be ... software match the graphics on the ... pins protruding from lower surface which ...
... The latest introduction in the family of ... design of the stepping platform features a ... scale. The EXII steeping unit has a ... visual display of transducer position and a ...
Medicine Products: